Yared Herouy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yared Herouy has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Erwin Schöpf
Department of Dermatology and
2 shared publicationsJ Norgauer
Department of Dermatology, University Hospital, D-79104-Freiburg, Germany
2 shared publicationsJohannes Norgauer
Department of Dermatology and
2 shared publicationsStefan Dichmann
Department of Dermatology and
2 shared publicationsC Hofmann
Department of Dermatology, University Hospital, D-79104-Freiburg, Germany
1 shared publicationC Stetter
Department of Dermatology, University Hospital, D-79104-Freiburg, Germany
1 shared publication
Latest Publications
- 1 March 2003
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 1 (3) , 191-198
Xeroderma Pigmentosum: Mondscheinkinder. Xeroderma Pigmentosum: Children of the Moon
Xeroderma pigmentosum is based on a genetic defect in the DNA repair system, which is diagnosed in early childhood. Xeroderma pigmentosum is a rare disorder, which is transmitted in an autosomal recessive manner. Children with xeroderma pigmentosum display hypersensitivity to ultraviolet (UV) radiation. These patients experience serious sunburns with minimal exposure and then develop poikiloderma in the sun-exposed areas. Squamous cell carcinomas, basal cell carcinomas and malignant melanomas all appear during childhood. The majority of patients do not reach adult, but die from metastatic cutaneous malignancies. Genetically, xeroderma pigmentosum is differentiated into 7 complementation groups (XP-A to XP-G) and the xeroderma pigmentosum variants (XP-V). The assignment to the specific complementation group is made by fusing of xeroderma pigmentosum fibroblasts. Xeroderma pigmentosum must be distinguished from other so-called DNA repair deficiency syndromes, including Cockayne syndrome and trichothiodystrophy. A topical DNA repair enzyme appears to be helpful. A recombinant liposomal encapsulated T4 endonuclease V repairs UV-induced cyclobutane-pyrimidine dimers. Direct curative treatment of xeroderma pigmentosum could be achieved with gene therapy in future. Transfection of an intact repair gene which specifically codes for the missing repair protein could open new possibilities in the therapy of xeroderma pigmentosum.
- 1 March 2003
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 1 (3) , 191-198
Xeroderma Pigmentosum: Mondscheinkinder. Xeroderma Pigmentosum: Children of the Moon
Xeroderma pigmentosum is based on a genetic defect in the DNA repair system, which is diagnosed in early childhood. Xeroderma pigmentosum is a rare disorder, which is transmitted in an autosomal recessive manner. Children with xeroderma pigmentosum display hypersensitivity to ultraviolet (UV) radiation. These patients experience serious sunburns with minimal exposure and then develop poikiloderma in the sun-exposed areas. Squamous cell carcinomas, basal cell carcinomas and malignant melanomas all appear during childhood. The majority of patients do not reach adult, but die from metastatic cutaneous malignancies. Genetically, xeroderma pigmentosum is differentiated into 7 complementation groups (XP-A to XP-G) and the xeroderma pigmentosum variants (XP-V). The assignment to the specific complementation group is made by fusing of xeroderma pigmentosum fibroblasts. Xeroderma pigmentosum must be distinguished from other so-called DNA repair deficiency syndromes, including Cockayne syndrome and trichothiodystrophy. A topical DNA repair enzyme appears to be helpful. A recombinant liposomal encapsulated T4 endonuclease V repairs UV-induced cyclobutane-pyrimidine dimers. Direct curative treatment of xeroderma pigmentosum could be achieved with gene therapy in future. Transfection of an intact repair gene which specifically codes for the missing repair protein could open new possibilities in the therapy of xeroderma pigmentosum.
- 1 July 2001
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 28 (6) , 291-297
The role of the urokinase‐type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis
Background: Lipodermatosclerosis refers to a sclerosing panniculitis and dermopathy of the lower extremities sometimes seen in association with venous ulceration. Matrix metalloproteinases are implicated in the pathogenesis of venous leg ulcers and the in vitro activation of recombinant MMP‐2 is controlled by the plasminogen activation system. To better understand the role of plasminogen activation in the pathogenesis of venous leg ulcers we investigated fibrinolytic factors and their inhibitors in tissue samples of lipodermatolsclerosis.Methods: The expression and the functional state of the urokinase‐type plasminogen activator (uPA), the tissue‐type plasminogen activator (tPA), the urokinase receptor (CD87), the plasminogen activator inhibitors‐1 and ‐2 (PAI‐1 and PAI‐2) were assayed using reverse transcription polymerase chain reaction, Western blot, fibrin zymography and immunohistochemistry analyses in tissue samples of lipodermatosclerosis.Results: Our results provide direct evidence of elevated expression of uPA (pConclusion: Our findings indicate that elevated plasminogen activation in lipodermatosclerotic tissue may play a crucial role in the pathogenesis of venous leg ulceration.
- 1 July 2001
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 28 (6) , 291-297
The role of the urokinase‐type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis
Background: Lipodermatosclerosis refers to a sclerosing panniculitis and dermopathy of the lower extremities sometimes seen in association with venous ulceration. Matrix metalloproteinases are implicated in the pathogenesis of venous leg ulcers and the in vitro activation of recombinant MMP‐2 is controlled by the plasminogen activation system. To better understand the role of plasminogen activation in the pathogenesis of venous leg ulcers we investigated fibrinolytic factors and their inhibitors in tissue samples of lipodermatolsclerosis.Methods: The expression and the functional state of the urokinase‐type plasminogen activator (uPA), the tissue‐type plasminogen activator (tPA), the urokinase receptor (CD87), the plasminogen activator inhibitors‐1 and ‐2 (PAI‐1 and PAI‐2) were assayed using reverse transcription polymerase chain reaction, Western blot, fibrin zymography and immunohistochemistry analyses in tissue samples of lipodermatosclerosis.Results: Our results provide direct evidence of elevated expression of uPA (pConclusion: Our findings indicate that elevated plasminogen activation in lipodermatosclerotic tissue may play a crucial role in the pathogenesis of venous leg ulceration.
- 1 April 2001
- Published by Elsevier in Journal of Dermatological Science
- Vol. 25 (3) , 198-205
Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression
- 1 April 2001
- Published by Elsevier in Journal of Dermatological Science
- Vol. 25 (3) , 198-205
Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression
- 1 January 2001
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 7 (1) , 3-15
Matrix metalloproteinases in skin pathology (Review).
Human tissue is composed in part of cells and in part of amorphous matrix components. Equilibrium exists between the synthesis and degradation of connective tissue under physiological conditions, which serves both the formation and the maintenance of tissue architecture. Synthesis progresses via mesenchymal cells, degradation is controlled by the proteolytic effect of a group of enzymes, which belong to the protein family of matrix metalloproteinases. In biological development, matrix metalloproteinases play an important role in all essential configurative processes in embryo- and histogenesis. As a result of the importance of matrix metalloproteinases in creation of connective tissue, dysregulation with excessive proteolytic activity may result in tissue damage. Histological structural changes are set in relation to the molecular expression pattern of matrix metalloproteinases using matrix relevant diseases of human skin. Discussion includes fibrosing processes, skin inflammations, wound healing, blistering diseases, premature sun-induced skin aging and primary cutaneous malignomas and their metastases.
- 1 January 2001
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 7 (1) , 3-15
Matrix metalloproteinases in skin pathology (Review).
Human tissue is composed in part of cells and in part of amorphous matrix components. Equilibrium exists between the synthesis and degradation of connective tissue under physiological conditions, which serves both the formation and the maintenance of tissue architecture. Synthesis progresses via mesenchymal cells, degradation is controlled by the proteolytic effect of a group of enzymes, which belong to the protein family of matrix metalloproteinases. In biological development, matrix metalloproteinases play an important role in all essential configurative processes in embryo- and histogenesis. As a result of the importance of matrix metalloproteinases in creation of connective tissue, dysregulation with excessive proteolytic activity may result in tissue damage. Histological structural changes are set in relation to the molecular expression pattern of matrix metalloproteinases using matrix relevant diseases of human skin. Discussion includes fibrosing processes, skin inflammations, wound healing, blistering diseases, premature sun-induced skin aging and primary cutaneous malignomas and their metastases.
- 1 November 2000
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 143 (5) , 930-936
Plasminogen activation in venous leg ulcers
Background Venous leg ulceration results from chronic venous insufficiency of the lower extremities. We recently showed that matrix metalloproteinase (MMP) ‐2 plays a major part in the pathogenesis ...
- 1 November 2000
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 143 (5) , 930-936
Plasminogen activation in venous leg ulcers
Background Venous leg ulceration results from chronic venous insufficiency of the lower extremities. We recently showed that matrix metalloproteinase (MMP) ‐2 plays a major part in the pathogenesis ...
- 1 November 2000
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 6 (5)
Autologous platelet-derived wound healing factor promotes angiogenesis via alphavbeta3-integrin expression in chronic wounds.
Healing of venous leg ulcers depends on the adhesive interaction and formation of new vascular cells. Angiogenesis on the surface of angiogenic blood vessels requires the vascular integrin alphavbeta3 also known as the vitronectin receptor. Autologous platelet-derived wound healing factor (autologous PDWHF) has been described to regulate the wound healing process by forming granulation tissue in the early healing phase. Here we analysed the influence of autologous PDWHF on the expression of the alphavbeta3 integrin in tissue specimen of venous leg ulcers in comparison with placebo treated controls by using reverse transcriptase-polymerase chain reaction and immunohistochemistry. Our investigations provide evidence that mRNA and protein expression of alphavbeta3 were significantly increased in healing venous leg ulcers after 96 h treatment (p<0.05), whereas the total amount of alphavbeta3 mRNA and protein was not altered in placebo treated patients. In healing leg ulcers the alphavbeta3 integrin was predominantly localized around capillary vessels preferentially at sites of newly formed granulation tissue. Placebo controlled patients displayed no altered expression of the alphavbeta3 integrin in biopsy specimen. These findings suggest that topical autologous platelet-derived wound healing factor influences the process of angiogenesis/revascularization via alphavbeta3 integrin-expression hereby promoting granulation tissue formation in healing leg ulcers.
- 1 November 2000
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 6 (5)
Autologous platelet-derived wound healing factor promotes angiogenesis via alphavbeta3-integrin expression in chronic wounds.
Healing of venous leg ulcers depends on the adhesive interaction and formation of new vascular cells. Angiogenesis on the surface of angiogenic blood vessels requires the vascular integrin alphavbeta3 also known as the vitronectin receptor. Autologous platelet-derived wound healing factor (autologous PDWHF) has been described to regulate the wound healing process by forming granulation tissue in the early healing phase. Here we analysed the influence of autologous PDWHF on the expression of the alphavbeta3 integrin in tissue specimen of venous leg ulcers in comparison with placebo treated controls by using reverse transcriptase-polymerase chain reaction and immunohistochemistry. Our investigations provide evidence that mRNA and protein expression of alphavbeta3 were significantly increased in healing venous leg ulcers after 96 h treatment (p<0.05), whereas the total amount of alphavbeta3 mRNA and protein was not altered in placebo treated patients. In healing leg ulcers the alphavbeta3 integrin was predominantly localized around capillary vessels preferentially at sites of newly formed granulation tissue. Placebo controlled patients displayed no altered expression of the alphavbeta3 integrin in biopsy specimen. These findings suggest that topical autologous platelet-derived wound healing factor influences the process of angiogenesis/revascularization via alphavbeta3 integrin-expression hereby promoting granulation tissue formation in healing leg ulcers.
- 22 March 2000
- Vol. 10 (3) , 173-80
Matrix metalloproteinases and venous leg ulceration.
Metalloproteinase-mediated proteolysis plays an important role during the phase of venous ulcer formation and wound repair. Venous ulcers manifest as a breakdown of the collagenous stromal tissue and are highly associated to chronic venous insufficiency. A major change in our understanding of the pathogenesis of venous ulcers occurred with the demonstration of extracellular matrix-degrading activity of matrix metalloproteinases to generate a dermal-epidermal skin defect. These proteases were intensely investigated in preceding stages and during wound repair of venous ulcerations. Different studies have revealed their significance in the process of proteolytic remodeling and recognized their potential importance in finding therapeutic rationales to manage late complications of chronic venous ulcers.
- 22 March 2000
- Vol. 10 (3) , 173-80
Matrix metalloproteinases and venous leg ulceration.
Metalloproteinase-mediated proteolysis plays an important role during the phase of venous ulcer formation and wound repair. Venous ulcers manifest as a breakdown of the collagenous stromal tissue and are highly associated to chronic venous insufficiency. A major change in our understanding of the pathogenesis of venous ulcers occurred with the demonstration of extracellular matrix-degrading activity of matrix metalloproteinases to generate a dermal-epidermal skin defect. These proteases were intensely investigated in preceding stages and during wound repair of venous ulcerations. Different studies have revealed their significance in the process of proteolytic remodeling and recognized their potential importance in finding therapeutic rationales to manage late complications of chronic venous ulcers.